Authors : Utkarsh Patel

Volume/Issue : Volume 10 - 2025, Issue 1 - January

Google Scholar : https://tinyurl.com/4357zt2h

Scribd : https://tinyurl.com/3snd83c9

DOI : https://doi.org/10.5281/zenodo.14759706

Abstract : Radiating discomfort greatly affects life quality and presents challenges for effective management. Gabapentin, a primary drug used for neuropathic discomfort, is essential in controlling pain. Nevertheless, the relative effectiveness of gabapentin alone compared to combination therapy (Ultracet or Akilose P) in treating radiating pain is still undetermined. This observational study aimed to evaluate and compare the treatment outcomes of gabapentin monotherapy and combination therapy for the control of widespread pain. A review was carried out on 100 individuals diagnosed with radiating discomfort, all of whom received treatment for four weeks at a specialized pain management facility. Information was gathered from the patients’ files, covering initial pain ratings, weekly VAS scores, and demographic details. Statistical evaluations were conducted using Welch’s t-test alongside descriptive statistics. In the gabapentin-only group, the average pain rating fell from 11.11 (at the start) to 5.10 (by week 4), indicating a 54.05% improvement. Likewise, the combination therapy group experienced a decline from 10.34 to 6.00, showing a 42.03% improvement. The difference between both groups was not statistically relevant (t=0.6818, p=0.4590). However, gabapentin alone exhibited superior tolerability and fewer adverse effects. The research emphasizes that gabapentin as a standalone treatment achieves significant pain reduction and is a more favorable long-term option due to its lower adverse effect profile. It is suggested that further studies with larger populations and longer timeframes are necessary to confirm these results and enhance treatment approaches.

Keywords : Radiating Pain, Gabapentin, Monotherapy, Combination Therapy, Randomized Controlled Trial, Visual Analog Scale.

References :

1. Atkinson, J. H., Slater, M. A., Capparelli, E. V., Patel, S. M., Wolfson, T., Gamst, A., et al. (2016). A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. PAIN, 157(7), 1499–1507. https://doi.org/10.1097/j.pain.0000000000000614
2. Spijker-Huiges, A., Groenhof, F., Winters, J. C., van Wijhe, M., Groenier, K. H., & van der Meer, K. (2015). Radiating low back pain in general practice: Incidence, prevalence, diagnosis, and long-term clinical course of illness. Scandinavian Journal of Primary Health Care, 33(1), 27–32. https://doi.org/10.3109/02813432.2015.1002595
3. Cavalli, E., Mammana, S., Nicoletti, F., Bramanti, P., & Mazzon, E. (2019). The neuropathic pain: An overview of the current treatment and future therapeutic approaches. International Journal of Immunopathology and Pharmacology, 33(33), 205873841983838. https://doi.org/10.1177/2058738419838383
4. van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014). Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain, 155(4), 654–662. https://doi.org/10.1016/j.pain.2013.11.013
5. Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Jackson, A. C., & Houlden, R. L. (2009). Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial. The Lancet, 374(9697), 1252–1261. https://doi.org/10.1016/S0140-6736(09)60953-2
6. Yasaei, R., Katta, S., & Saadabadi, A. (2020). Gabapentin. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459455/
7. Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994). A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care, 17(12), 1281–1289. https://doi.org/10.2337/diacare.17.12.1281
8. Martindale: The Complete Drug Reference. (2016). Tramadol hydrochloride. MedicinesComplete. Retrieved January 9, 2017, from https://www.medicinescomplete.com/mc/
9. Bensen, G. P., Rogers, A. C., Leifer, V. P., Edwards, R. R., Neogi, T., Kostic, A. M., et al. (2023). Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis. Osteoarthritis and Cartilage, 31(2), 279–290. https://doi.org/10.1016/j.joca.2022.12.015
10. Downie, W. W., Leatham, P. A., Rhind, V. M., Wright, V., Branco, J. A., & Anderson, J. A. (1978). Studies with pain rating scales. Annals of the Rheumatic Diseases, 37(4), 378–381. https://doi.org/10.1136/ard.37.4.378
11. Smith, B. H., Penny, K. I., Purves, A. M., Munro, C., Wilson, B., Grimshaw, J., Chambers, W. A., & Smith, W. C. (1997). The Chronic Pain Grade questionnaire: Validation and reliability in postal research. Pain, 71(1), 141–147. https://doi.org/10.1016/S0304-3959(97)03347-2
12. Raspe, H., Huppe, A., & Matthis, C. (2003). Theories and models of chronicity: On the way to a broader definition of chronic back pain. Schmerz, 17(5), 359–366. https://doi.org/10.1007/s00482-003-0233-y
13. Von Korff, M., & Miglioretti, D. L. (2005). A prognostic approach to defining chronic pain. Pain, 117(3), 304–313. https://doi.org/10.1016/j.pain.2005.06.027
14. Bolton, J. E., & Wilkinson, R. C. (1998). Responsiveness of pain scales: A comparison of three pain intensity measures in chiropractic patients. Journal of Manipulative and Physiological Therapeutics, 21(1), 1–7. https://doi.org/10.1016/S0161-4754(98)80002-0
15. Linton, S. J. (1991). Memory for chronic pain intensity: Correlates of accuracy. Perceptual and Motor Skills, 72(4), 1091–1095. https://doi.org/10.2466/pms.72.4.1091-1095
16. Mishra, P., Singh, U., Pandey, C., Mishra, P., & Pandey, G. (2019). Application of student’s t-test, analysis of variance, and covariance. Annals of Cardiac Anaesthesia, 22(4), 407–411. https://doi.org/10.4103/aca.ACA_156_19
17. Kinkade, S. (2007). Evaluation and treatment of acute low back pain. PubMed, 75(8), 1181–1188. https://pubmed.ncbi.nlm.nih.gov/17483401/
18. Dayer, P., Desmeules, J., & Collart, L. (1997). Pharmacology of tramadol. Drugs, 53(Suppl 2), 18-24. https://doi.org/10.2165/00003495-199753002-00003.
19. Chandrasekharan, N. V., Dai, H., Roos, K. L., Evanson, N. K., Tomsik, J., Elton, T. S., et al. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proceedings of the National Academy of Sciences of the United States of America, 99(22), 13926–13931. https://doi.org/10.1073/pnas.212457299
20. Tallarida, R. J., & Raffa, R. B. (1996). Testing for synergism over a range of fixed ratio drug combinations: Replacing the isobologram. Life Sciences, 58(23), PL23-28. https://doi.org/10.1016/0024-3205(96)00233-X.
21. Smith, A., Jones, J., & Smith, B. (2018). Polypharmacy within the elderly: A writing audit. Journal of Drug Store Management, 31(2), 195–204. https://doi.org/10.1016/j.jds.2017.12.005